CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-19 | Rubino Alan L Director | Option exercise · Stock Option (right to buy) | −5,000 | 0 | ||
| 2021-03-01 | Colangelo Dominick President and CEO | Sale | −1,548 | $48.47 | $75K | 217,647 |
| 2021-03-01 | Colangelo Dominick President and CEO | Sale | −2,260 | $48.78 | $110K | 215,387 |
| 2021-03-01 | Colangelo Dominick President and CEO | Option exercise | +5,625 | $2.65 | $15K | 221,012 |
| 2021-03-01 | Colangelo Dominick President and CEO | Option exercise | +6,805 | $7.20 | $49K | 227,817 |
| 2021-03-01 | Colangelo Dominick President and CEO | Option exercise | +15,925 | $2.75 | $44K | 243,742 |
| 2021-03-01 | Colangelo Dominick President and CEO | Sale | −27,500 | $48.06 | $1.3M | 216,242 |
| 2021-03-01 | Colangelo Dominick President and CEO | Sale | −8,692 | $48.01 | $417K | 207,550 |
| 2021-03-01 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −5,625 | 28,125 | ||
| 2021-03-01 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −6,805 | 293,195 | ||
| 2021-03-01 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −15,925 | 49,700 | ||
| 2021-02-19 | Colangelo Dominick President and CEO | Grant or award · Stock Option (right to buy) | +298,055 | 298,055 | ||
| 2021-02-19 | Colangelo Dominick President and CEO | Grant or award · Stock Option (right to buy) | +1,945 | 1,945 | ||
| 2021-02-19 | Colangelo Dominick President and CEO | Grant or award · Restricted Stock Unit | +35,750 | 35,750 | ||
| 2021-02-19 | Flynn Sean C. VP, General Counsel | Grant or award · Stock Option (right to buy) | +3,890 | 3,890 | ||
| 2021-02-19 | Flynn Sean C. VP, General Counsel | Grant or award · Restricted Stock Unit | +7,000 | 7,000 | ||
| 2021-02-19 | Flynn Sean C. VP, General Counsel | Grant or award · Stock Option (right to buy) | +56,110 | 56,110 | ||
| 2021-02-19 | Halpin Michael Chief Operating Officer | Grant or award · Stock Option (right to buy) | +1,945 | 1,945 | ||
| 2021-02-19 | Halpin Michael Chief Operating Officer | Grant or award · Stock Option (right to buy) | +98,055 | 98,055 | ||
| 2021-02-19 | Halpin Michael Chief Operating Officer | Grant or award · Restricted Stock Unit | +11,250 | 11,250 |
Page 51 of 75 · 1,497 trades